Saturday, August 25, 2012

Non-Valvular Artial Fibrillation Drug Xarelto® (Rivaroxaban), Studies Investigate Benefits

Patients with Atrial Fibrillation (AF) who undergo cardioversion or catheter ablation therapy are at particular risk of stroke and require effective anticoagulation before and after these procedures...

via Medical News Today

No comments:

Post a Comment